Click here to view the United Healthcare (UHC) Medical Policy Updates » November 2024 United…
Moda Health Plan December 2017 Medical Policy Updates
Click here to view the Moda Health Plan Medical Policy Updates »
- Aldurazyme (laronidase) (last updated 10/2017)
- Alimta® (pemetrexed) (last updated 11/2017)
- Aloxi (palonesetron) (last updated 11/2017)
- Aranesp (darbepoetin alfa) Erythropoiesis Stimulating Agents (ESAs) (last updated 11/2017)
- Bendeka™ (bendamustine hcl) (last updated 11/2017)
- Beleodaq (belinostat) (last updated 11/2017)
- Cyramza (ramucirumab) (last updated 11/2017)
- Darzalex™ (daratumumab) (last updated 11/2017)
- Elaprase (idursulfase) (last updated 10/2017)
- Empliciti (elotuzumab) (last updated 11/2017)
- Erbitux® (cetuximab) (last updated 11/2017)
- Epogen/Procrit (epoetin alfa) Erythropoiesis Stimulating Agents (ESAs) (last updated 11/2017)
- Fusilev (levoleucovorin) (last updated 11/2017)
- Gazyva (obinutuzumab) (last updated 11/2017)
- Granix (tbo-filgrastim) (Colony Stimulating Factors) (last updated 11/2017)
- Halaven (eribulin mesylate) (last updated 11/2017)
- Hyaluronic Acid Derivatives (Durolane®, Euflexxa™, Gel-One®, GelSyn-3™, GenVisc 850®, Hyalgan™, Hymovis®, Monovisc®, Orthovisc™, Supartz/Supartz FX™, Synvisc™, & Synvisc-One™, Visco-3™) (last updated 11/2017) (last updated 11/2017)
- Jevtana (cabazitaxel) (last updated 11/2017)
- Kadcyla® (ado-trastuzumab emtansine) (last updated 11/2017)
- Lumizyme (alglucosidease alfa) (last updated 10/2017)
- Marqibo (vincristine sulfate liposomal) (last updated 11/2017)
- Mental Health Partial Hospitalization and Intensive Outpatient Treatment (last updated 7/2017)
- Mental Health Residential-Children, Adolescents and Adults (last updated 7/2017)
- Naglazyme (galsulfase) (last updated 10/2017)
- Neupogen (filgrastim) (Colony Stimulating Factors) (last updated 11/2017)
- Obstructive Sleep Apnea Non-Surgical Treatment (last updated 12/2017)
- Obstructive Sleep Apnea Surgical Treatment (last updated 3/2017)
- Onivyde™ (irinotecan liposome injection) (last updated 11/2017)
- Perjeta (Pertuzumab) (last updated 11/2017)
- Portrazza™ (necitumumab) (last updated 11/2017)
- Sandostatin® LAR (octreotide) (last updated 11/2017)
- Simponi ARIA (golimumab) (intravenous) (last updated 12/2017)
- Stelara (ustekinumab) (last updated 10/2017)
- Tecentriq (atezolizumab) (last updated 11/2017)
- Vectibix (panitumumab) (last updated 11/2017)
- Velcade® (bortezomib) (last updated 11/2017)
- Yescarta™ (axicabtagene ciloleucel) (new effective 12/1/2017)
- Yondelis (trabectedin) (last updated 11/2017)
- Zaltrap® (ziv-aflibercept) (last updated 11/2017)
- Zarxio (filgrastim-sndz) (Colony Stimulating Factors) (last updated 11/2017)
Click here to view the Moda Health Plan Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!
Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.